Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Cancer
|
July 3, 2023
A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma
Shetal A Patel, Michael K Gibson, Allison Deal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2023
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer
Julie E Bauman, Nabil F Saba, Denise Roe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2025
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma
Dan P Zandberg, Jacob B Allred, Ari J Rosenberg, et al.
Journal of Palliative Medicine
|
April 13, 2021
A Pilot Study of a Collaborative Palliative and Oncology Care Intervention for Patients with Head and Neck Cancer
Jessica R Bauman, Jessie R Panick, Thomas J Galloway, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 5, 2025
Long-Term Feeding Tube Use in Head and Neck Cancer Survivors-An Analysis of Patient- and Treatment-Related Factors
Thomas J Galloway, Stephanie L Pugh, John A Ridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 7, 2020
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin Contraindication
Jared Weiss, Siddharth Sheth, Allison M Deal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 9, 2017
NCCN Guidelines Insights: Palliative Care, Version 2.2017
Maria Dans, Thomas Smith, Anthony Back, et al.
JCO Precision Oncology
|
December 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (<i>NRG1</i>) Fusions
Tejas Patil, Jessica J Lin, Parneet K Cheema, et al.
JCO Precision Oncology
|
October 16, 2024
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study
Francis P Worden, Evan Pisick, Michael Rothe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 23, 2026
First-line integration of Local Ablative Therapy (LAT) with EGFR Tyrosine Kinase Inhibitors (TKIs) in advanced EGFR+ NSCLC: A Systematic Review and Meta-Analysis
Leonardo Brunetti, Giacomo Colella, Giuseppina Rita Di Fazio, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Cancer
|
July 3, 2023
A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma
Shetal A Patel, Michael K Gibson, Allison Deal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2023
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer
Julie E Bauman, Nabil F Saba, Denise Roe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2025
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma
Dan P Zandberg, Jacob B Allred, Ari J Rosenberg, et al.
Journal of Palliative Medicine
|
April 13, 2021
A Pilot Study of a Collaborative Palliative and Oncology Care Intervention for Patients with Head and Neck Cancer
Jessica R Bauman, Jessie R Panick, Thomas J Galloway, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 5, 2025
Long-Term Feeding Tube Use in Head and Neck Cancer Survivors-An Analysis of Patient- and Treatment-Related Factors
Thomas J Galloway, Stephanie L Pugh, John A Ridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 7, 2020
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin Contraindication
Jared Weiss, Siddharth Sheth, Allison M Deal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 9, 2017
NCCN Guidelines Insights: Palliative Care, Version 2.2017
Maria Dans, Thomas Smith, Anthony Back, et al.
JCO Precision Oncology
|
December 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (<i>NRG1</i>) Fusions
Tejas Patil, Jessica J Lin, Parneet K Cheema, et al.
JCO Precision Oncology
|
October 16, 2024
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study
Francis P Worden, Evan Pisick, Michael Rothe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 23, 2026
First-line integration of Local Ablative Therapy (LAT) with EGFR Tyrosine Kinase Inhibitors (TKIs) in advanced EGFR+ NSCLC: A Systematic Review and Meta-Analysis
Leonardo Brunetti, Giacomo Colella, Giuseppina Rita Di Fazio, et al.
Page
of 5